Literature DB >> 16861239

Antibody-mediated pure red cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole erythropoietic agent.

Abraham Jacob1, Kanwaljit Sandhu, Johann Nicholas, Helen Jones, Jonathan Odum, Paul Rylance, Paul Carmichael, Maurice Jackson, Sunil Handa, Alan Macwhannell, Supratik Basu, Faisal Wahid, Nicole Casadevall, Ghulam Mufti, Iain Macdougall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16861239     DOI： 10.1093/ndt/gfl331

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  7 in total

1.  Tungsten-induced denaturation and aggregation of epoetin alfa during primary packaging as a cause of immunogenicity.

Authors:  Andreas Seidl; Otmar Hainzl; Marleen Richter; Robert Fischer; Stephan Böhm; Britta Deutel; Martin Hartinger; Jörg Windisch; Nicole Casadevall; Gerard Michel London; Iain Macdougall
Journal:  Pharm Res       Date:  2011-11-18       Impact factor: 4.200

Review 2.  Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.

Authors:  Walter H Hörl
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

3.  Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).

Authors:  Iain C Macdougall; Nicole Casadevall; Francesco Locatelli; Christian Combe; Gerard M London; Salvatore Di Paolo; Andreas Kribben; Danilo Fliser; Hans Messner; John McNeil; Paul Stevens; Antonio Santoro; Angel L M De Francisco; Paul Percheson; Anna Potamianou; Arnaud Foucher; Daniel Fife; Véronique Mérit; Els Vercammen
Journal:  Nephrol Dial Transplant       Date:  2014-09-19       Impact factor: 5.992

4.  Antibody-mediated pure red cell aplasia (PRCA) on switching from darbepoetin alfa to epoetin beta: what are the implications?

Authors:  José Assunção; José Vinhas
Journal:  NDT Plus       Date:  2008-06-10

5.  Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients.

Authors:  Maryam Rahbar; Zahra Chitsazian; Firoozeh Abdoli; Seyed-Masoud Moeini Taba; Hosein Akbari
Journal:  J Nephropathol       Date:  2016-08-22

6.  Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone.

Authors:  Nozomi Okahashi; Masayuki Kubo; Ei Hoshino; Masahito Uchihara; Itsuto Amano; Haruyuki Tanaka
Journal:  Intern Med       Date:  2021-12-28       Impact factor: 1.282

7.  Acquired Pure Red Cell Aplasia Following Recombinant Erythropoietin (Darbepoetin-alfa) Therapy.

Authors:  Somanath Padhi; Gayatri Behera; Sandeep Abhijit Pattnaik; Prabodh Kumar Das; Amit Kumar Adhya; Susama Patra
Journal:  Indian J Nephrol       Date:  2019-09-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.